Phase XXX Type II Diabetes study with renal complications

X October 2017 – Another endocrinology success for MDP Group. MDP Group will partner a European biotech with enrollment open to men and women on a Phase XXX Type II Diabetes study with renal complications. This trial will take place at our sites in Saint Petersburg.